| Class / Patent application number | Description | Number of patent applications / Date published |
|---|
| 424547000 | Derived from mollusk | 21 |
| 20080199533 | Cosmetic and skin care formulation containing pearls, teas and fruits - The present invention relates to a cosmetic and skin care formulation comprising: at least one pearl selected from a group consisting essentially of cultured pearls, Japanese natural pearls, cultured pearls, freshwater pearls, salt water pearls, keshi pearls, mabe pearls and mixtures thereof; at least one tea selected from a group consisting essentially of white tea, black tea, green tea, red tea, oolong tea, herbal tea and mixtures thereof; and at least one fruit selected from a group consisting essentially of miracle fruit, Barbados cherry, peanut butter fruit, sugar apple, wampi, imbé, Spanish lime, langsat, black sapote, papaya, velvet apple, mabolo, soursop, guanabana, mangosteen, okari nut, passion fruit, rambutan, banana, plantain, mango, sapodilla, red banana, canistel, egg fruit, citron, pummelo, monstera, green papaya, pineapple, durian, star fruit, coconut, Jake fruit, pomegranate and mixtures thereof. | 08-21-2008 |
| 20080274205 | Ena Mineral Bioactive Solution, Manufacturing Method Thereof and Its Application for the Osteoporosis Prevention - The present invention is related to a method of manufacture of an alkaline mineral bioactive solution of which raw materials are squid bones burnt at a high temperature and crushed powder of red seaweeds and to compositions and health foods having the efficacy for the prevention of osteoporosis. The alkaline aqueous solutions having abundant minerals of the present invention may be used for bioactive solutions having the efficacy for the prevention and improvement of osseous diseases such as osteolysis and osteoporosis in mammals including human beings. | 11-06-2008 |
| 20090123559 | Medicine to Treat Drug Addiction and Preparation Method Thereof - The present invention declares a pharmaceutical extract, composition that has effect to treat drug addiction, and its preparation method and quality control method. This extract is extracted from Radix Stephaniae Epigaeae. Starting medicine material of said composition is Radix Ginseng, Radix Astragali, Rhizoma Corydalis, Radix Angelicae Sinensis and Radix Ophiopogonis; and said composition also can prepared by ethanol extract of Radix Ginseng, ethanol extract of Radix Angelicae Sinensis, total alkaloids of Radix Stephaniae Epigaeae, water extract of Radix Astragali and water extract of Radix Ophiopogonis. Quality control method of said pharmaceutical composition includes one of or several of identifications and content determinations. The present invention also declares the use of said pharmaceutical extract, composition in the preparation of a medicine to treat drug addiction. | 05-14-2009 |
| 20100297254 | NUTRACEUTICAL COMPOSITION AND METHODS OF USE - A method of treatment for cartilage degradation in an organism, which includes administering to an organism a composition including a therapeutic amount of an extract from the plant | 11-25-2010 |
| 20110045099 | NUTRACEUTICAL COMPOSITION AND METHODS OF USE - A method of modulating inflammation in an organism, which includes administering to an organism a composition including a therapeutic amount of an extract from the plant | 02-24-2011 |
| 20110262552 | Compositions Comprising Plant Extracts and Use Thereof for Treating Inflammation - Provided are compositions comprising | 10-27-2011 |
| 20110287107 | POROUS BIOCERAMIC COMPOSITION FOR BONE REPAIR - The present invention relates to a porous bioceramic composition for bone repair and method of fabrication of the same. 3D-scaffolds were fabricated with a novel micro- and macro-architecture. Porous scaffolds based on dextrin, dextran, gelatin and biomineral (CaCO | 11-24-2011 |
| 20120070506 | Animal Treatment - The present invention relates to a composition for an animal within a particular weight range including at least one non-steroidal anti-inflammatory drug (NSAID) compound and at least one mussel extract characterised in that the therapeutic dose of NSAID compound in the composition is substantially less than the usual therapeutic dose. | 03-22-2012 |
| 20120107410 | PRODUCT FOR THE PREPARATION OF DERMATOLOGICAL, COSMETIC OR COSMECEUTICAL COMPOSITIONS INTENDED FOR SKIN TREATMENT - The present invention relates to a product obtained from gastropod spawn, to be used to prepare dermatological, cosmetic or cosmeceutical compositions designed for skin care; said product has the capacity to activate and mobilise skin stem cells, as well as prevent the loss thereof that takes place as a consequence of chronological and premature ageing. The present invention also relates to the process followed in order to obtain said product. | 05-03-2012 |
| 20120148680 | EYE CREAM AND PREPARATION METHOD - The invention discloses an eye cream, comprising the following components in part by weight: 2-16 parts of pearl, 0.2-2 parts of borax, 10-28 parts of VE, 0.005-0.05 parts of muscone, 0.2-3 parts of borneol, 30-90 parts of complexe contour des yeux 338Y324 and 0.05-2 parts of zinc carbonate hydroxide. The eye cream has strong moisturizing ability and continuous water lock effect, good abilities of inhibiting melanin and increasing skin lightness, and at the same time has the effects of improving skin texture, i.e. delaying skin aging. | 06-14-2012 |
| 20120195970 | Homeopathic Formulations For Treatment Of Herpes Virus Symptoms - Compositions and methods of preparing and using such compositions to treat the symptoms of herpes virus. | 08-02-2012 |
| 20120231087 | Compositions And Methods for Nutritional Supplementation - The present invention relates to nutritional supplement compositions comprising krill meal and lipid insoluble ingredients. The compositions can be used to provide supplementary nutrition to humans or animals. The present invention relates also formulations, such as tablets, which are easy to administer to animals. It is also shown that krill meal added to animal food at low levels will improve the palatability of the product. | 09-13-2012 |
| 20130064898 | CHINESE MEDICINE COMPOSITION FOR TREATING CANCER - A composition for treating tumors caused by pancreatic, stomach, breast, or liver cancer, leukemia, lung or liver metastasis, and/or arterial aneurysm. The composition comprises in various parts; turtle shell, radix ranunculi ternati, rhizoma dioscoreae bulbiferae, concha arcae, fructus ligustri lucidi, cordyceps sinensis, dwarf lilyturf tuber, Whim brownii, radix astragali, angelica sinensis, radix pseudostellariae, spina date seed, fruit-spike of common selfheal, pericarpium citri reticulatae, costustoot, cape jasmine fruit, radix scrophulariae, radix rehmanniae, rhizoma corydalis, safflower, turmeric root-tuber, cortex moutan, concha ostreae, poria cocos, herba lysimachiae, the root of red-rooted salvia, isatis indigotica fort, honeysuckle, fructus forsythiae, cortex eucommiae, radix gentianae macrophyllae, radix paeoniae alba, subprostrate sophora, seman platycladi, snakegourd fruit, membrane of chicken gizzard, platycodon grandifiorum, and radix liquiritiae. | 03-14-2013 |
| 20130084342 | PHARMACEUTICAL COMPOSITION - A method of treating a respiratory disease in an animal comprising the steps of administering to the animal an effective amount of a pharmaceutical composition comprising 1.5 parts by weight powdered fennel, 2.0 parts by weight powdered rhubarb, 1.0 part by weight powdered glycyrrhiza, 2.0 parts by weight powdered phellodendron bark, 1.0 part by weight powdered zedoary, 1.5 parts by weight powdered picrasma wood, 1.0 part by weight powdered matricaria chamomilla, 1.5 parts by weight powdered geranium herb, 1.0 part by weight powdered ginseng, 1.5 parts by weight powdered citrus unshiu peel, 1.0 part by weight powdered scutellaria root, 1.0 part by weight powdered magnolia bark, 2.0 parts by weight powdered oyster shell, 1.0 part by weight powdered cyperus rhizome, 2.0 parts by weight powdered platycodon root, 2.0 parts by weight powdered melia azedarach, 1.0 part by weight powdered cnidium rhizome, 2.0 parts by weight sodium bicarbonate and 4.0 parts by weight precipitated calcium carbonate in 30 parts by weight of the composition. | 04-04-2013 |
| 20130259952 | TIE2 Activator, Vascular Endothelial Growth Factor (VEGF) Inhibitor, Angiogenesis Inhibitor, Vascular Maturing Agent, Vascular Normalizing Agent and Vascular Stabilizing Agent, and Pharmaceutical Composition - A Tie2 activator containing, as an active ingredient, a hawthorn extract, a starfruit extract, a shellflower extract, a lotus extract, a rooibos extract, an Indian date extract, a Chinese quince extract, a Psidium guava extract, a long pepper extract, a Quillaja extract, a Kouki extract, a ginkgo extract, an oyster extract, a turmeric extract, a chrysanthemum extract, a jujube extract, a Chinese wolfberry extract, a chamomile extract, or a Butcher's Broom extract, or any combination thereof. | 10-03-2013 |
| 20130337079 | METHOD FOR PRODUCING OYSTER MEAT ESSENCE CONTAINING LARGE AMOUNT OF ANTIOXIDANTS HAVING HIGH ANTIOXIDATIVE POWER AND HIGH ORAC VALUE - To provide a method for producing an oyster meat essence that more amply incorporates an antioxidant substance with high ORAC value as follows. A portion of an oyster meat extract more amply incorporating an antioxidant substance with high ORAC value is selected. An extraction method that allows incorporating further large amount of antioxidant substance with high ORAC value is employed. The beneficial oyster meat extract can be efficiently extracted in large amounts. | 12-19-2013 |
| 20140106001 | MARINE EXTRACT COMPOSITIONS AND METHODS OF USE - Compositions comprising extracts from marine organisms show beneficial effects on skin ailments. Fine lines, wrinkles, and sagging in skin are improved with the application of compositions with marine extracts. Production of collagen, elastin and hyaluronic acid are increased after application of the compositions. | 04-17-2014 |
| 20150125542 | TIE2 Activator, Vascular Endothelial Growth Factor (VEGF) Inhibitor, Angiogenesis Inhibitor, Vascular Maturing Agent, Vascular Normalizing Agent and Vascular Stabilizing Agent, and Pharmaceutical Composition - A Tie2 activator containing, as an active ingredient, a hawthorn extract, a starfruit extract, a shellflower extract, a lotus extract, a rooibos extract, an Indian date extract, a Chinese quince extract, a Psidium guava extract, a long pepper extract, a Quillaja extract, a Kouki extract, a ginkgo extract, an oyster extract, a turmeric extract, a chrysanthemum extract, a jujube extract, a Chinese wolfberry extract, a chamomile extract, or a Butcher's Broom extract, or any combination thereof. | 05-07-2015 |
| 20150290251 | USE OF EGGSHELL MEMBRANE FORMULATIONS TO ALLEVIATE JOINT PAIN - A method to treat and alleviate symptoms of joint pain in an individual is accomplished by administering a therapeutic amount of fowl eggshell membrane or processed eggshell membrane preparations in synergistic combination with other active constituents in an oral dosage form. | 10-15-2015 |
| 20150352168 | Pharmaceutical Composition for Treating Headache, and Preparation Method Thereof - A pharmaceutical composition for treating headache, prepared from eleven Chinese herbal medicines: Chinese angelica root, ligusticum chuanxiong, radix paeoniae lactiflorae, prepared rhizome of rehmannia, uncaria tomentosa, leatherleaf milletia, prunella vulgaris, sicklesenna seed, pearl shell, corydalis tuber, and asarum, and a proper amount of adjuvant materials. A preparation method of the pharmaceutical composition, and uses thereof in the preparation of drugs for treating various headaches, traumatic cranial nerve syndrome, dizziness and vertigo, vexation and irritability, insomnia and dreaminess. | 12-10-2015 |
| 20160038531 | FAST ACTING JOINT RELIEF FORMULATIONS - The instant invention provides a method and composition for treating or preventing osteoarthritis, joint effusion, joint inflammation and pain, synovitis, lameness, post operative arthroscopic surgery, deterioration of proper joint function including joint mobility, the reduction or inhibition of metabolic activity of chondrocytes, the activity of enzymes that degrade cartilage, said method comprising administering effective amounts of | 02-11-2016 |
